CNNC Fuzhi Officially Established, CNNC Isotope Holds 90% Stake to Integrate the Full Nuclear Medicine Industry Chain
On August 6, 2026, CNNC Fuzhi (Beijing) Technology Co., Ltd. (hereinafter referred to as "CNNC Fuzhi") was officially established. The company was jointly funded by CNNC Isotope Co., Ltd. (hereinafter referred to as "CNNC Isotope") and CNNC (Zhejiang) Innovation Co., Ltd. (hereinafter referred to as "CNNC Zhejiang Innovation"), with CNNC Isotope holding 90% of the shares and CNNC Zhejiang Innovation holding 10%. CNNC Fuzhi will take over the business of CNNC Isotope's Nuclear Medicine Development Center, focusing on deep cultivation in the smart nuclear medicine sector. With the smart nuclear medicine IoT system as its core carrier, the company aims to integrate the entire nuclear medicine industry chain, build a synergistic development model of "smart nuclear medicine system + nuclear drugs + equipment + services," and drive the business transition from single product supply to full value chain integration...
2026-08-08
